Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (BMS).
Phase of Trial: Phase IV
Latest Information Update: 06 Sep 2011
At a glance
- Drugs Aripiprazole (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 28 Apr 2011 Planned number of patients changed from 8 to 20.
- 13 Nov 2005 New trial record.